8 results match your criteria: "St. George's Hospital Medical School London[Affiliation]"
Am J Obstet Gynecol
September 2000
Department of Medical Genetics and the Department of Obstetrics and Gynaecology, St George's Hospital Medical School. London, United, Kingdom.
Objective: Our aim was to evaluate the detection of fetal cells from transcervical samples by means of fluorescence in situ hybridization analysis.
Study Design: Forty-seven women undergoing first-trimester termination of pregnancy were recruited for transcervical sampling and 16 were recruited for endocervical mucus aspiration. Subjects were asked to assess the discomfort of the procedure.
Ann R Coll Surg Engl
January 1999
University Department of Surgery, St George's Hospital Medical School London.
Br J Pharmacol
November 1998
Division of Gastroenterology, Endocrinology and Metabolism, St George's Hospital Medical School London.
1. Effects of the synthetic vitamin D analogue EB1089 on indices of apoptosis in cultured human breast cancer cells and in nitrosomethylurea-induced rat mammary tumours in vivo were investigated. 2.
View Article and Find Full Text PDFGlycoconj J
November 1997
Division of Immunology, St. George's Hospital Medical School London, UK.
Br J Pharmacol
April 1994
Department of Pharmacology & Clinical Pharmacology, St. George's Hospital Medical School London.
1. Single isolated cells were obtained from the taenia of the guinea-pig's caecum by enzymic digestion and held under voltage clamp. The effects of various catecholamines, sympathomimetics and related compounds were tested for their ability to potentiate the voltage-dependent calcium current (ICa) evoked in these cells by a depolarizing step.
View Article and Find Full Text PDFInt J Gynaecol Obstet
February 1988
Department of Obstetrics & Gynaecology, St. George's Hospital Medical School London, U.K.
Two hundred fifty subfertile men with idiopathic oligospermia (count less than 20 million/ml) were treated with mesterolone (100-150 mg/day) for 12 months. Seminal analysis were assayed 3 times and serum follicle stimulating hormone (FSH) luteinizing hormone (LH) and plasma testosterone were assayed once before treatment and repeated at 3, 6, 9 and 12 months after the initiation of treatment. One hundred ten patients (44%) had normal serum FSH, LH and plasma testosterone, 85 patients (34%) had low serum FSH, LH and low plasma testosterone.
View Article and Find Full Text PDFImmunol Today
January 1983
Department of Immunology, St George's Hospital Medical School London SW17 ORE, U.K.